Diebold Nixdorf, Incorporated (DBD) key performance indicators and operating metrics (10 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Operating expense % of revenue | 17.10 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 11.20 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization (Non-GAAP) | 99.1M | FY2026-Q1 |
| Free Cash Flow (Non-GAAP) | 20.7M | FY2026-Q1 |
| Net Cash Provided by Operating Activities (GAAP) | 31.7M | FY2026-Q1 |
| Adjusted Earnings Per Share (Non-GAAP) | 0.67 USD_per_share | FY2026-Q1 |
| Adjusted EBITDA | 164M | FY2025-Q4 |
| Gross Margin (Non-GAAP) | 26.20 percent | FY2025-Q3 |
| Net Leverage | 1.60 ratio | FY2025-Q3 |
| Share Repurchase Authorization | 200M | FY2025-Q3 |
Back to DBD overview · DBD earnings · DBD holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.